Rock Creek Pharmaceuticals, Inc. (RCPI) Starts Presentation at LD Micro Invitational Conference

Rock Creek Pharmaceuticals (OTC: RCPI) is an emerging drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic and acute inflammatory diseases. The company’s compound is a small molecule, cholinergic agonist that exhibits anti-inflammatory pharmacological characteristics, distinct from other anti-inflammatory drugs. Rock Creek’s lead compound has been investigated extensively in pre-clinical studies resulting in several peer reviewed and published scientific journal articles, covering models of multiple sclerosis, Alzheimer’s disease, and autoimmune thyroiditis. For more information, visit the company’s website at www.rockcreekpharmaceuticals.com